These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 7683061)
1. Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction. Montorsi F; Guazzoni G; Bergamaschi F; Ferini-Strambi L; Barbieri L; Rigatti P J Urol; 1993 May; 149(5 Pt 2):1291-5. PubMed ID: 7683061 [TBL] [Abstract][Full Text] [Related]
2. Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence. Montorsi F; Guazzoni G; Bergamaschi F; Zucconi M; Rigatti P; Pizzini G; Miani A; Pozza G Acta Diabetol; 1994 Apr; 31(1):1-5. PubMed ID: 8043890 [TBL] [Abstract][Full Text] [Related]
3. [Intracavernous injection of vasoactive drugs for treating erectile impotence]. Yasumoto R; Asakawa M; Kawashima H; Yoshimura R; Maekawa T; Kashiwara N; Tanaka H; Nishio S Hinyokika Kiyo; 1988 Feb; 34(2):301-4. PubMed ID: 2454019 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence. Montorsi F; Guazzoni G; Bergamaschi F; Dodesini A; Rigatti P; Pizzini G; Miani A Urology; 1993 Nov; 42(5):554-8. PubMed ID: 7694416 [TBL] [Abstract][Full Text] [Related]
5. Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients. Sidi AA; Cameron JS; Duffy LM; Lange PH J Urol; 1986 Apr; 135(4):704-6. PubMed ID: 2421014 [TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation]. Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119 [TBL] [Abstract][Full Text] [Related]
7. [Intracavernous pharmacotherapy for treatment and evaluation of impotence]. Vardi Y; Lidgi S; Moskovitz B; Levin RD Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307 [TBL] [Abstract][Full Text] [Related]
8. Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose. von Heyden B; Donatucci CF; Kaula N; Lue TF J Urol; 1993 May; 149(5 Pt 2):1288-90. PubMed ID: 8479018 [TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. Lee LM; Stevenson RW; Szasz G J Urol; 1989 Mar; 141(3):549-50. PubMed ID: 2918589 [TBL] [Abstract][Full Text] [Related]
10. Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1. Allen RP; Engel RM; Smolev JK; Brendler CB J Urol; 1992 Oct; 148(4):1181-3. PubMed ID: 1404632 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection]. Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609 [TBL] [Abstract][Full Text] [Related]
12. Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction. Chao R; Clowers DE Arch Phys Med Rehabil; 1994 Mar; 75(3):276-8. PubMed ID: 8129578 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction. Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187 [TBL] [Abstract][Full Text] [Related]
14. Vasoactive intracavernous pharmacotherapy for the treatment of erectile impotence in men with spinal cord injury. Sidi AA; Cameron JS; Dykstra DD; Reinberg Y; Lange PH J Urol; 1987 Sep; 138(3):539-42. PubMed ID: 2442418 [TBL] [Abstract][Full Text] [Related]
15. Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men. Richter S; Vardi Y; Ringel A; Shalev M; Nissenkorn I Int J Impot Res; 2001 Jun; 13(3):172-5. PubMed ID: 11525316 [TBL] [Abstract][Full Text] [Related]